InvestorsHub Logo
Followers 1
Posts 11
Boards Moderated 0
Alias Born 02/28/2014

Re: alertmeipp post# 11465

Monday, 03/31/2014 4:21:32 PM

Monday, March 31, 2014 4:21:32 PM

Post# of 20689
Yes, I guess so. It is priced to be launched at Sept. 2015. Only long term bull like to hold it. Considering the bio-sector is out of money flow and no major event in the coming months. So it is likely to drift lower to test last year low around 10.15 area. I think FDA will wait for the legal dust settles first. I think SAC may cut loss and shorter are in control. The long term bull thinks it is a value play, but the momentum is down-trend. Let's hope analysts come out to downgrade MNTA to make big fund to load up so it can go up soon. I will wait to see if price of 11.22 holds so that I can buy my other half back.

AS Teva jumps to 52 weeks high, MNTA will have a long way to go.
It is very hard to value MNTA, because cash burn-rate is so high that in 12 months, 2$ is off. If market is down 5%, MNTA will down 10%.